经导管主动脉瓣置换术后的心脏手术
单中心回顾性分析2012年1月至2020年7月59例TAVR后接受心脏手术的患者(中位年龄70岁,38例64%在其他中心完成TAVR)。TAVR后心脏手术量增加、间隔缩短;多为复杂高危再次手术,单纯主动脉瓣置换罕见;手术死亡5例(8.5%),术后卒中2例(3.4%),术后透析6例(10%)。
要点
- TAVR后心脏手术逐年增加,2019年达18例,TAVR与手术间隔从7年指数级缩短至不足1年。
- 手术指征以TAVR瓣狭窄/反流34例(58%)最常见,其次瓣周漏14例(24%)、心内膜炎10例(17%)。
- 46例(78%)取出TAVR瓣,仅5例为单纯主动脉瓣置换;手术死亡5例(8.5%)。
核心结论
- TAVR后心脏手术不断增加,TAVR与手术间隔不断缩短;多数为复杂高危再次手术,单纯主动脉瓣置换罕见。
- 作者认为在为低至中危患者选择TAVR时,尤其存在TAVR未处理的多种心脏病变时,应考虑这些发现。
研究设计与样本
- 单中心回顾性研究,纳入2012年1月至2020年7月共59例TAVR后接受心脏手术的患者,中位年龄70岁,其中38例(64%)手术在其他中心完成。
- 在既往TAVR时及适用的本次心脏手术时计算胸外科医师学会预测死亡风险(STS-PROM)。
主要发现
- 2012年至2018年每年TAVR后心脏手术少于10例,2019年达18例;TAVR与心脏手术间隔随经验积累从7年指数级缩短至不足1年。
- 在19例(32%)可计算STS-PROM的病例中,中位STS-PROM为5.5%(第15至85百分位,3.1%-25%),另40例(68%)为无法计算STS-PROM的复杂手术。
- TAVR瓣被取出46例(78%),其中单纯外科主动脉瓣置换5例;未取出TAVR瓣时,二尖瓣反流是主要手术指征。
- 手术死亡5例(8.5%),术后卒中2例(3.4%),术后透析6例(10%)。
关键数值与推荐
- TAVR后心脏手术主要指征:TAVR瓣狭窄/反流34例(58%),瓣周漏14例(24%),心内膜炎10例(17%)。
- 可计算STS-PROM的19例中,中位STS-PROM为5.5%(第15至85百分位,3.1%-25%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Transcatheter aortic valve replacement (TAVR) is now frequently performed for severe aortic stenosis. Data regarding cardiac operations after TAVR are limited, however. Therefore, we investigated patient characteristics, operative timing and indications, and outcomes of these operations in a single-center experience. METHODS: From January 2012 to July 2020, 59 patients (median age, 70 years) underwent cardiac operations after TAVR, 38 (64%) of which were performed in other centers. The Society of Thoracic Surgeons Predicted Risk of Mortality (STS-PROM) was calculated at the time of prior TAVRs and at applicable index cardiac operations. RESULTS: From 2012 to 2018, fewer than 10 operations were performed after TAVR, but 18 were performed in 2019. The interval between prior TAVR and cardiac surgery decreased exponentially from 7 years to less than 1 year over the experience. In applicable cases (19 of 59 operations [32%]), the median STS-PROM was 5.5% (15th-85th percentiles, 3.1%-25%), and 40 (68%) were complex operations with no calculable STS-PROM. The TAVR valve was explanted in 46 (78%); 5 were isolated surgical aortic valve replacements. TAVR valve stenosis/regurgitation (34 [58%]) was the leading indication, followed by paravalvular leak in 14 (24%) and endocarditis in 10 (17%). When the TAVR valve was not explanted, mitral regurgitation was the leading indication for operation. Operative death occurred in 5 (8.5%), postoperative stroke in 2 (3.4%), and postoperative dialysis in 6 (10%). CONCLUSIONS: Cardiac operations after TAVR are increasing, and the interval between TAVR and operation is decreasing. Most cardiac operations are complex, high-risk reoperations, and isolated aortic valve replacement is rare. These findings should be considered when TAVR is selected for low- to intermediate-risk patients, particularly with multiple cardiac pathologies not addressed by TAVR.
引用
- Yun JJ, Saleh OA, Chung JW, et al. Cardiac Operations After Transcatheter Aortic Valve Replacement. Ann Thorac Surg. 2021. PMID: 34800488. doi:10.1016/j.athoracsur.2021.10.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。